BPC-157 / TB-500 Capsules
US$ 28.56
snap 8 and ghk cu cream SNAP-8 GHK-Cu Copper Peptide Renewal GHK-Cu SNAP-8 Peptide Serum |
Description
Clinical evidence: The SURMOUNT-1 trial, published in the New England Journal of Medicine , showed that participants on the highest dose of tirzepatide (15 mg) lost an average of 22.5 percent of their body weight over 72 weeks the most weight loss ever demonstrated by a pharmaceutical agent in a clinical trial (Jastreboff et al., 2022)
Not the shiny platform
19 Exploratory analyses of qEEG changes demonstrated significant changes indicating a direct influence on the nervous system, and these changes were seen only for the active NSI-189 group
Are food and refreshments included
